IL-18, and neurotoxic cytokines TNF-α, IL-1α, and C1q expression and extracellular secretion are increased. The released cytokines are functional since culture supernatants from ssRNA40 exposed microglia-induced toxicity of human primary neurons. Moreover, inflammasome activation of microglia increased ROS generation with a loss of mitochondrial membrane potential and mitochondrial integrity. Treatment with ssRNA40 resulted in a blockade of autophagy/ mitophagy mediated negative regulation of NLRP3 inflammasome activity with the release of inflammatory cytokines, caspase-1 activation, and pyroptotic microglial cell death. Thus, HIV ssRNA mediated activation of microglial cells can contribute to neurotoxicity and neurodegeneration via secretion of inflammatory and neurotoxic cytokines. These findings provide a potential mechanism that explains the frequent minor cognitive deficits and chronic inflammation that persist in HIV-infected persons despite treatment with suppressive ART.
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| INTRODUCTION
Combination antiretroviral therapy (ART) has greatly reduced the burden of illness associated with human immunodeficiency virus type-1 (HIV) infection and led to strategies capable of significantly reducing transmission (Cohen et al., 2016 ). An important contributor to the improvement in the overall outcome of HIV-infected persons has been the marked decline of HIV-associated dementia. However, although the severe neurological disease is now uncommon with ART, minor cognitive impairment persists and may occur in from 10% to 20% of infected patients on treatment (Farhadian, Patel, & Spudich, 2017; Heaton et al., 2015) HIV enters the central nervous system (CNS) during primary infection predominantly infecting microglia and macrophages (Burdo, Lackner, & Williams, 2013; Garden, 2002) . Although actively replicating virus is detected within the CNS in those with HIV-associated dementia, infectious virus is uncommonly detected in cerebrospinal fluid in patients fully suppressed on ART (Anderson et al., 2017) . However, despite the ability of ART to provide sustained viral suppression, markers of chronic inflammation remain elevated suggesting that low level HIV replication and/or release of viral RNA and proteins may be driving the persistent inflammatory response (Baxter, O'Doherty, & Kaufmann, 2018; Eden et al., 2016; Garden, 2002; Golumbeanu et al., 2018; Pollack et al., 2017; Shan et al., 2017) Much research has examined the effects of HIV on the CNS.
However, the mechanistic causes of HIV-associated neurological disorders (HAND) remain mostly unknown. Interleukin-1β (IL-1β) has been associated with HIV disease progression, and is released during NLR family pyrin domain containing 3 (NLRP3) inflammasome activation (Chattergoon et al., 2014; Chen, Partridge, Sell, Torres, & Martin-Garcia, 2017; Guo, Gao, Taxman, Ting, & Su, 2014) . Recent reports suggest that NLRP3 inflammasome activation is associated with the enhanced appearance of mitochondria damage signals and subsequent mitochondrial destabilization in host cells (Gurung, Lukens, & Kanneganti, 2015; Misawa et al., 2013; Nakahira et al., 2011; Shimada et al., 2012; Yu et al., 2014) . To minimize the deleterious effects of damaged mitochondria, cells employ selective autophagy of mitochondria, mitophagy, which has a critical role in maintaining the health of cells by promoting the turnover and preventing the accumulation of damaged mitochondria that can lead to cellular degeneration. The mitochondrial serine/threonine kinase PTEN induced putative kinase 1 (PINK1) and the cytolytic E3 ubiquitin ligase Parkin, play an important role in mitophagy (Lazarou, Jin, Kane, & Youle, 2012; Matsuda et al., 2010; Narendra, Tanaka, Suen, & Youle, 2008; Narendra, Jin, et al., 2010) . In addition, autophagy receptors including p62/SQSTM1, Optineurin (OPTN), neighbor of BRCA1 (NBR1), and nuclear DOT protein 52 kDa (NDP52) bind polyubiquitinated cargo through the ubiquitin-binding domain (UBD) and target them to the autophagy/mitophagy pathway by interacting with LC3 through their LC3 interacting region (LIR) domain .
Recent studies suggest that NDP52 and OPTN are the primary receptors for PINK1 and Parkin-mediated mitophagy Lazarou et al., 2015) . PINK1 can specifically recruit these receptors directly on the damaged mitochondria to mediate both Parkindependent and Parkin-independent mitophagy (Lazarou et al., 2015) .
Several studies have implicated NLRP3 inflammasome activation to be associated with neuroinflammation and HAND (Bandera et al., 2018; Feria, Taborda, Hernandez, & Rugeles, 2018; Marais et al., 2017; Walsh et al., 2014) . However, the mechanism(s) driving the inflammatory process during sustained HIV suppression have not been identified. Here, we show that GU-rich RNA from the HIV long terminal repeat region (LTR) signaling through TLR-7 and -8 on microglial cells results in activation of the NLRP3 inflammasome with the release of neurotoxic cytokines resulting in degeneration of primary human neurons (HPN).
| MATERIALS AND METHODS

| Ethics statement
Healthy HIV seronegative donors were enrolled for venous blood draw using a protocol that was reviewed and approved by the Human 
| Cell culture
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood of HIV seronegative donors using density gradient centrifugation over Ficoll-Paque Plus (GE Healthcare, Chicago, IL Cat# 17144003). Primary human monocytes were isolated from PBMCs using monocyte isolation kit II, human (Miltenyi Biotech, Bergisch Gladbach, . Human microglia cells (HMG) were differentiated from primary human monocytes using methods as described previously (Etemad, Zamin, Ruitenberg, & Filgueira, 2012; Rawat & Spector, 2017) . Briefly, monocytes were seeded at 2.5 × 10 5 cells/well in a 48-well plate in serum-free RPMI Glutamax medium (Gibco, Dublin, Ireland Cat# 61870036) supplemented with M-CSF (10 ng/ml; Peprotech, Rocky Hill, NJ Cat# 300-25), MCP1 (100 ng/ml; Peprotech, Rocky Hill, NJ Cat# 300-04), GM-CSF (10 ng/ml; Peprotech, Rocky Hill, NJ Cat# 300-03) and NGF-β (10 ng/ml; R&D Systems, Minneapolis, MN Cat# 256-GF-100) with media changed every 3 days.
For autophagy induction in HMG cells, the culture medium was supplemented with trehalose (Sigma-Aldrich, St. Louis, MO Cat# T0167) at 100 mM concentration. The lysosomal degradation inhibitor bafilomycin A1 (Cell Signaling, Danvers, MA Cat# 54645) was prepared in dimethyl sulfoxide (DMSO) and added to the medium at a concentration of 10 nM to measure the autophagic flux. DMSO was added to the medium of untreated cells as vehicle control.
| Human microglia isolation and cell culture
Human fetal brain-derived microglia cells (HFMG) were isolated as previously described (Rawat & Spector, 2017) . Briefly, human fetal brainderived cells were plated at a density of~7 × 10 6 cells/ml in a T75 tissue culture flask in DMEM high glucose (Gibco, Dublin, Ireland Cat# 11965084) supplemented with 10% AB-human serum (MP Biomedicals, Santa Ana, CA Cat# 092938249) and M-CSF (10 ng/ml). After 10-14 days, flasks were shaken and floating microglia were collected and cultured at a density of 2.5 × 10 5 cells/well in a 48-well plate.
| Human primary neuron isolation and cell culture
For isolation of human primary neurons (HPN), forebrain fetal tissue was obtained from Advanced Bioscience Resources (Alameda, CA) and from the University of Washington, School of Medicine according to the University of California San Diego Institutional Review Board guidelines and processed as previously described (Avramut, Zeevi, & Achim, 2001; Teodorof et al., 2014 Data were analyzed using FlowJo v10 software (Tree Star). 
| Immunofluorescence microscopy
| Statistical analysis
Comparison between groups was performed using the paired, twotailed, Student's t test, or one-way ANOVA as appropriate. Differences with a p value < .05 were considered statistically significant.
| RESULTS
| HIV-1 RNA primes expression of inflammasome molecules and neurotoxic cytokines in microglial cells
Inflammation is thought to play a central role in HIV-associated neurological disorders that persist despite sustained viral suppression with ART. Since during suppressive treatment, the replication-competent virus can be absent but HIV mRNA remains detectable, we designed our initial experiments to examine the effect of GU-rich ssRNA within the HIV LTR (ssRNA40) on human primary monocyte-derived microglia (HMG) cell activation of inflammatory markers associated with the NLRP3 inflammasome. We chose ssRNA40 because the mRNAs from the HIV LTR can be made despite ART suppression (Baxter et al., 2018; Golumbeanu et al., 2018; Pollack et al., 2017) and ssRNA40 is known to signal through TLR7/8 (Alter et al., 2007; Guo et al., 2014) . exposed HMG (p < .001, Figure 2b ) and suggest that the NLRP3 inflammasome pathway is induced in microglia following treatment with ssRNA40 for 24 hr (Figure 2b ). In addition, we also confirmed by ELISA the release of C1q, IL-1α, and TNF-α in the culture supernatants derived from ssRNA40 exposed HMG (Figure 2c ). Similar to the induction of inflammatory cytokines, key neurotoxic cytokines were exclusively released from HMG exposed to ssRNA40 (p < .01, Figure 2c ). None of these inflammatory and neurotoxic cytokines were observed in the ssRNA41 exposed microglial cell culture supernatants (Figure 2b ,c).
Although we have shown previously that HMG closely resembles HFMG at both the molecular and physiological levels (Rawat & Spector, 2017) , we assessed in the limited number of HFMG available if IL-18, IL-1β, C1q, IL-1α, and TNF-α were also upregulated following exposure with ssRNA40. Following the same methods used for HMG, each of the key cytokines previously identified were also found to be upregulated by protein expression and secretion in HFMG culture supernatants (Figure 3a ,b).
| HIV RNA mediated activation of microglial cells is neurotoxic to HPN
Although to this point, we had shown that specific cytokines and chemokines are released during ssRNA40 mediated activation of microglial cells, it was important to identify the functional activity of these proteins to induce neurotoxicity of HPNs. After confirming the NLRP3 inflammasome priming event, we next analyzed its activation in presence of ssRNA40. MCC950 is a known potent and selective small molecule inhibitor of NLRP3 that specifically inhibits activation of the NLRP3 inflammasome and reduces IL-1β production in vivo (Coll et al., 2015) . Here, HMG were pretreated with MCC950 or the caspase-1 inhibitor Ac-YVAD-cmk for 2 hr, after which cells were treated with ssRNA40 for 24 hr. Post 24 hr incubation, cell culture supernatants were analyzed for IL-1β, IL-1α, and TNF-α release. NLRP3 inflammasome inhibition by MCC950 significantly reduced the processing and release of IL-1β following ssRNA40 treatment. Overall, there was >50% reduction in IL-1β and IL-1α release in culture supernatants following MCC950 and AcYVAD-fmk pretreatment compared to untreated ssRNA40 exposed microglial cells (p < .01, Figure 5b ). Since TNF-α secretion is not Figure 6d ). These mitochondrial studies further confirm that ssRNA40 mediated NLRP3 inflammasome activation is associated with loss of mitochondrial integrity and ROS generation (Figures 6a-d) . HIV ssRNA40 activates NLRP3 inflammasome and inhibits the expression of its negative regulator, miR-223. (a) HMG cells were treated with ssRNA40 for 24 and 48 hr; NLRP3 levels were analyzed with qPCR (top) and immunoblotting (bottom). Left: representative immunoblots for NLRP3 and β-actin using antibody to NLRP3 and human β-actin and right, densitometric analysis for fold change in NLRP3 expression from three independent donors. Results are presented as mean AE SD, n = 3; *p < .05. (b) Pharmacologic inhibition of NLRP3 by MCC950 inhibits ssRNA40 induced inflammasome activation in microglia cells. HMG cells were pretreated with NLRP3 inflammasome inhibitor, MCC950 (10 μM), or caspase-1-specific inhibitor Ac-YVAD-cmk (50 μM), or vehicle control prior to their exposure to ssRNA40, ssRNA41 or vehicle control and production of IL-1β, IL-1α, and TNF-α in culture supernatants were measured at 24 hr post-treatment by ELISA. (c) HMG cells were exposed to ssRNA40 (5 μg/ml), ssRNA41 or vehicle control and monitored for expression of miR-223, and NLRP3 mRNA at 24 and 48 hr post-treatment time points. Results are presented as mean AE SD, n = 3; *p < .05
| Expression of PINK1 and Parkin is increased following ssRNA40 induced mitochondrial damage in human microglia
Several neurodegenerative disorders including Parkinson's disease and
Alzheimer's disease exhibit signs of mitochondrial damage and inflammasome activation (Golpich et al., 2017; Guo, Callaway, & Ting, 2015; Saresella et al., 2016; Sarkar et al., 2017) . Mitochondrial destabilization and damage enhance the release of mitochondrial DNA and ROS generation. Additionally, the inhibition of mitophagy/autophagy leads to the accumulation of ROS generating damaged mitochondria leading to the activation of the NLRP3 inflammasome (Nakahira et al., 2011; Saitoh et al., 2008; Zhou et al., 2011) . Autophagy receptors, NBR1, OPTN, p62/SQSTM1, NDP52, and TAX1BP1 also play an important regulatory role during inflammasome activity by binding to damaged mitochondria and subsequently targeting them for autophagic degradation by binding to LC3 Lazarou et al., 2015) . In the case of LPS primed macrophages, p62/SQSTM1 is specifically induced in an NF-κB-dependent manner and restricts excessive inflammasome activation (Zhong et al., 2016) . Numerous studies also suggest that autophagy receptors play an important role in regulating the inflammasome activity by elimination of these damaged mitochondria and thus prevent excessive inflammasome activation, IL-1β release and caspase-1 induced death (pyroptosis) (Shi et al., 2012; Takahama, Akira, & Saitoh, 2018; Yu et al., 2014) . Therefore, in our next set of experiments, we analyzed the expression of autophagy receptors, p62/SQSTM1, NDP52, and OPTN in ssRNA40 exposed HMG. HMG cells were treated with vehicle, ssRNA40 or ssRNA41 for 24 hr as previously described and expression of specific autophagy receptors was analyzed by qPCR and immunoblotting. Following treatment with ssRNA40, expression of p62/SQSTM1 and OPTN was significantly induced at both mRNA (p < .05; Figure 7a ) and protein level (p < .005; Figure 7b ) compared to ssRNA41 treated control cells.
However, a small but not significant increase was observed in NDP52 expression (p = .27, Figure 7a ; p = .22, Figure 7b ).
PINK1 recruits Parkin to the depolarized mitochondria to drive mitophagy (Narendra et al., 2008; Narendra, Jin, et al., 2010) . Previous studies have identified an important role for PINK1 and Parkin proteins in the elimination of damaged mitochondria through mitophagy (Matsuda et al., 2010; Narendra et al., 2008; Narendra, Jin, et al., 2010) . Thus, in addition to other autophagy receptors, we also examined PINK1-Parkin-mediated mitophagy in ssRNA40 exposed HMG.
Microglial cells were treated as described above, and PINK1 and Parkin protein expression were analyzed by immunoblotting at 24 hr post-treatment (Figure 7c ). Microglia stimulation with ssRNA40 resulted in a 2-fold increase in PINK1 expression and 2.5-fold increase in Parkin expression compared to control HMG (p < .05, Figure 7c ).
Next, we determined the recruitment of these receptors in ssRNA40 
| Inflammasome activation and inhibition of mitophagy leads to caspase-1-dependent cell death of microglial cells
The NLRP3 inflammasome complex typically consists of three major components, the receptor NLRP3, the adaptor ASC, and effector caspase-1. In normal resting cells, ASC displays a soluble cytoplasmic localization, but upon inflammasome activation, ASC receptor is mobilized to form a large single perinuclear polymeric structure, "ASC speckle", an important marker for inflammasome activation (Cai et al., 2014; Franklin et al., 2014; Lu et al., 2014) . Thus, to further confirm inflammasome activation, we assessed the development of ASC speckle formation in microglia in the presence of ssRNA40 (Figure 9a ).
For these experiments, HMG were treated with vehicle, ssRNA41 or ssRNA40 for 24 or 48 hr, and stained with ASC (green; Figure 9a ).
NLRP3 inflammasome activation by ssRNA40 induced formation of perinuclear ASC speckle specifically in ssRNA40 treated HMG cells (Figure 9a ), while vehicle and ssRNA41 treated cells displayed a diffuse cytoplasmic localization for ASC (Figure 9a ).
To this point, our findings demonstrate that ssRNA40 triggers the NLRP3 inflammasome and induces mitochondrial damage in microglial cells. However, in some cell types, activation of autophagy and mitophagy can negatively regulate NLRP3 by targeting the ubiquitinated mitochondria and inflammasome for degradation (Nakahira et al., 2011; Shi et al., 2012) . Therefore, our next studies were designed to determine whether ssRNA40 mediated inflammasome activation is regulated by autophagy/mitophagy in microglial cells. HMG cells were exposed to vehicle, ssRNA41 or ssRNA40 for 24 or 48 hr, and stained with Tom20/OPTN and Tom20/Poly-Ubiquitin (Poly-Ub) to identify damaged mitochondria aggregates in response to ssRNA40 induced inflammasome activation (Figure 9b,c) . Following ssRNA40 exposure, OPTN and Poly-Ub aggregates localized near perinuclear regions and co-localized with Tom20 (Figure 9b,c) . These findings suggest that ssRNA40 induced NLRP3 inflammasome activation increases mitochondrial aggregates in microglial cells which are poorly eliminated by autophagy/mitophagy as indicated by the continued presence of FIGURE 6. Legend on next page.
these aggregates at 48 hr post-ssRNA40 stimulation (bottom, Figure 9b ,c).
Having identified that autophagy-mediated elimination of damaged mitochondria and regulation of inflammasome activity is impaired in ssRNA40 exposed microglia cells, we next assessed the expression levels of key autophagy and mitophagy proteins in ssRNA40 exposed HMG. Lysates prepared from microglial cells treated with ssRNA40, ssRNA41, and vehicle were analyzed for expression of autophagy-related proteins NDP52, OPTN, p62/SQSTM1, LC3B-II, and BECN1 and mitophagy associated proteins pTBK1 and
Parkin by immunoblotting (Figure 9d and Supporting Information Figure S1 ). At 24 hr, autophagy receptors OPTN and p62/SQSTM1 expression increased by 6-and 2.4-fold, respectively. By 48 hr, OPTN remained elevated while p62/SQSTM1 returned to the level of controls ( Figure 9d and Supporting Information Figure S1a ). Core autophagy proteins, LC3B-II and BECN1, expression remained unchanged following ssRNA40 treatment of microglia at both time points suggesting that autophagy fails to go to completion (Figure 9d and Supporting Information Figure S1b ).
We further confirmed the block in mitophagy by analyzing the turnover of autophagy receptors OPTN, SQSTM1, and NDP52 in a cycloheximide chase experiment (Supporting Information Figure S2 Figure S2 ). SQSTM1 expression was decreased regardless of when cycloheximide treatment was initiated (0, 6, 12, and 24 hr) post-ssRNA40 exposure. However, when cycloheximide was administered at 24 hr post-ssRNA40 exposure the inhibition of SQSTM1 was less (Supporting Information Figure S2 ). These data suggest that autophagy receptor expression is induced in the presence of ssRNA40 to regulate the early inflammasome activity. However, the reduced turnover following continuous exposure to ssRNA40 results in lower autophagymediated control of late inflammasome activity in microglial cells.
The mitophagy associated protein, pTBK1, which increases recruitment of OPTN on damaged mitochondria, increased 6.5-fold at 24 hr (top, Figure 9c) , and similar to OPTN and p62/SQSTM1
remained increased but to a lesser extent (2-fold) at 48 hr postexposure ( Figure 9d and Supporting Information Figure S1c) . Similarly, >3-fold increase was observed in mitophagy receptor, Parkin, expression at 24 hr and remained increased but to a lesser extent (2-fold) at 48 hr post-ssRNA40 treatment (top, Figure 9d and Supporting Information Figure S1c ). The absence of regulatory functions of autophagy during inflammasome activation can activate caspase-1 and induce caspase-1 mediated pro-inflammatory cell death called pyroptosis (Yu et al., 2014) . We measured the caspase-1 activation mediated cell death (pyroptosis) in ssRNA40 exposed HMG cells. Cells were stained for active caspase-1 and aqua viability stain and analyzed by flow cytometry (Figure 10a ). HIV ssRNA40 exposed HMG cells showed 3-fold increase in active caspase-1 mediated cell death (Figure 10a ). 3.8 | Induction of autophagy reduces ssRNA40 induced inflammasome activity and cell death
Having found that autophagy-mediated regulation of inflammasome activity is impaired in ssRNA40 exposed microglial cells, we next assessed whether induction of autophagy can rescue ssRNA40
induced inflammasome activity and cell death. Although rapamycin is often used as a mTOR-dependent inducer of autophagy, it can have a paradoxical effect on inflammation (Dupont et al., 2011; Weichhart et al., 2011; Yang et al., 2015) . For this reason, in these studies we have used trehalose, a known mTOR-independent inducer of autophagy which has been shown to promote clearance of toxic aggregates in several models of neurodegenerative disease (Du, Liang, Xu, Sun, & Wang, 2013; Sarkar, 2013; Sarkar, Davies, Huang, Tunnacliffe, & Rubinsztein, 2007; Tanaka et al., 2004; Zhang et al., 2014) .
After pretreatment of HMG with trehalose (100 mM) and exposure with ssRNA40 for 24 hr, LC3B lipidation was 3-fold higher compared to controls (p = .01, Figure 11a ). To confirm that the increased lipidation is due to increased autophagic flux, HMG were treated with bafilomycin A1, a known disrupter of autophagic flux by inhibiting VATPase-dependent acidification and CA-P60A/SERCA-dependent A1 treatment leading to accumulation of LC3B-II (p < .005, Figure 11a ). We further confirmed these findings using confocal immunofluorescence microscopy ( Figure 11b ). Thus, autophagy FIGURE 10. Legend on next page.
induction significantly enhanced the LC3B lipidation in ssRNA40 treated cells (Figure 11a,b) .
Next, we examined whether induction of autophagy by trehalose reduces ssRNA40 induced inflammasome activity and cell death. HMG were pretreated with trehalose prior to exposure to ssRNA40 and at 48 hr cell lysates were analyzed for pro-IL-1β expression, and supernatants for IL-1β secretion and LDH release. In the presence of trehalose, ssRNA40 induced inflammasome activation was significantly reduced as indicated by a decrease in pro-IL-1β expression (top, Figure 11c ) and >20-fold decrease in IL-1β release (bottom, Figure 11c , p < .005). Trehalose treatment also reduced ssRNA40 induced inflammasome-mediated cell death by >50% (p < .005, Figure 11d ).
Having established that reduced autophagy/mitophagy mediated regulatory function in ssRNA40 treated microglia leads to excessive release of inflammatory cytokines, we were interested in identifying the mechanism(s) by which ssRNA40 modulates autophagy. Previous studies have shown that autophagy machinery can deliver pathogen-associated molecular patterns (PAMPs) to endosomal TLRs (Ling et al., 2006) , and a subset of TLR ligands are known to control autophagy upon recognition by TLRs (Campbell & Spector, 2012; Delgado, Elmaoued, Davis, Kyei, & Deretic, 2008; Heil et al., 2004 ). These studies demonstrate that HIV ssRNA40 can be recognized through TLR7 and TLR8 expressed in macrophage endosomes. Therefore, we examined whether the ssRNA40 mediated inflammasome activation is dependent on TLR7/8 signaling in microglia (Supporting Information Figure S3 ). Following knockdown of TLR7 and TLR8 using siRNA (Supporting Information Figure S3a ), inflammasome activation and IL-1β release were decreased by 50, 60, and 70% in TLR7, TLR8 and TLR7/8 depleted microglial cells, respectively (Supporting Information Figure S3b ). Next, we examined whether TLR7/8 controls autophagy in ssRNA40 treated microglia. LC3B lipidation and expression of autophagy/mitophagy receptors OPTN and p62/SQSTM1 were assessed in TLR7, TLR8, and TLR7/8 depleted microglial cells in presence of ssRNA40 and compared to controls (Supporting Information Figure S3c ). Partial knockdown of TLR7/8 did not produce a significant change in LC3B lipidation in ssRNA40 treated microglia cells (Supporting Information Figure S3c ). However, OPTN and p62/SQSTM1 expression were decreased >two-fold in TLR8 and TLR7/8 depleted cells (p < .05, Supporting Information Figure S3c ).
This decrease was not observed in TLR7 reduced cells suggesting that TLR8 signaling in microglia may have a greater role in ssRNA40 mediated inflammasome activation (Supporting Information Figure S3c ).
| DISCUSSION
In the era of effective ART, chronic inflammation is increasingly being identified as an important potential mechanism leading to an increased risk of many disorders including accelerated aging, cardiovascular disease, and cognitive impairment. How HIV promotes inflammation despite the lack of detectable replication competent virus remains poorly understood. Recent studies demonstrating the presence of HIV transcripts without the detection of infectious virus (Baxter et al., 2018; Golumbeanu et al., 2018; Pollack et al., 2017) suggested to us that viral RNA that continues to be made in latent reservoirs could be an important driver of inflammation. In the findings reported here, we have identified that GU-rich HIV ssRNA from the LTR known to signal through TLR-7/8
induces IL-1β and IL-18 in human microglial cells through the induction of the NLRP3 inflammasome. Consistent with previous findings that reported induction of neurotoxic reactive astrocytes by activated microglia, ssRNA40 activated human microglia also induced neurotoxicity in primary human neurons through secretion of C1q, IL-1α, and TNF-α cytokines (Liddelow et al., 2017) .
Prior studies of RNA viruses including influenza, encephalomyocarditis virus, vesicular stomatitis virus, and HIV suggest that the NLRP3 inflammasome is a common pathway of the host innate antiviral response against RNA viruses (Chattergoon et al., 2014; Guo et al., 2014; Ichinohe, Pang, & Iwasaki, 2010; Rajan, Rodriguez, Miao, & Aderem, 2011) . Influenza virus and HIV were previously reported to induce NLRP3-dependent IL-1β secretion in infected macrophages and monocytes, respectively (Guo et al., 2014; Ichinohe et al., 2010 ).
Here we demonstrate that HIV ssRNA40 alone is sufficient to induce both IL-1β expression and caspase-1-dependent processing and IL-1β secretion in human microglial cells. Unlike influenza virus, HIV ssRNA40 serves as a potent trigger for robust NLRP3 activation in human microglia even in absence of active virus replication.
NLRP3 inflammasome activation is thought to require two signals.
Signal 1 primes the expression of pro-IL-1β, pro-IL-18, and NLRP3, and signal 2 drives the caspase-1 activation and processing of IL-1β
and IL-18 (Guo et al., 2015; Kanneganti, 2010) . Many RNA viruses activate signal 1 through TLR7 mediated recognition of ssRNA and priming of pro-IL-1β expression (Chattergoon et al., 2014; Diebold, Kaisho, Hemmi, Akira, & Reis e Sousa, 2004; Lehnardt, 2010; Lund et al., 2004) ; however, the mechanism of activation is not clearly defined for most of these viruses. In the case of influenza virus, the M2 protein serves as a second signal and triggers robust NLRP3 Results are presented as mean AE SD, n = 3; *p < .05
FIGURE 11 Induction of autophagy reduces ssRNA40 mediated inflammasome activity and cell death. HMG cells were pretreated with trehalose (100 mM) for 6 hr prior to their exposure to ssRNA40 (5 μg/ml). Bafilomycin A1 (Baf ) co-treatment with trehalose was used to confirm the increase in autophagic flux in the presence of trehalose. LyoVec and ssRNA41 (5 μg/ml) treated cells were used as controls. At 24 hr postssRNA40 treatment, cells were harvested and analyzed for LC3B lipidation by immunoblotting and confocal immunofluorescence microscopy. activation and caspase-1-dependent IL-1β secretion (Ichinohe et al., 2010) . Similarly, HIV ssRNA sensing via TLR7/TLR8 primes expression of pro-IL-1β, pro-IL-18, and NLRP3 in human primary microglia. However, for microglial cells following ssRNA40 exposure, mitochondrial damage and ROS generation may serve as the second signal to drive NLRP3 inflammasome activation, and IL-1β and IL-18 secretion.
Several previous reports suggest that autophagy is a key regulator of NLRP3 inflammasome activity (Nakahira et al., 2011; Shi et al., 2012) .
PINK1-Parkin mediated selective mitophagy is known to limit inflammasome activity by targeting the ubiquitinated damaged mitochondria for degradation and prevents their accumulation and ROS generation that can otherwise amplify the NLRP3 inflammasome response (Shi et al., 2012; Tschopp & Schroder, 2010) . Autophagy receptors NDP52 and OPTN were previously reported to play a key role in PINK1-Parkinmediated mitophagy and exhibit tissue specific expression (Lazarou et al., 2015) . Specifically, the mitochondrial fraction from brain tissue is reported to have the high expression for OPTN and p62 with minimal expression for NDP52 (Lazarou et al., 2015) . Similarly, we have identified that OPTN and p62 are increased whereas NDP52 was not induced in microglial cells following exposure to ssRNA40.
PINK1-Parkin-dependent TBK1 activation also plays a key role in recruitment of autophagy receptors OPTN and NDP52 on damaged mitochondria following mitochondrial depolarization to promote mitophagy (Heo, Ordureau, Paulo, Rinehart, & Harper, 2015; Richter et al., 2016) . Consistent with prior reports, we found that following 24 hr exposure of microglia to ssRNA40, TBK1 activation is enhanced as indicated by its increased phosphorylation and recruitment of autophagy receptors OPTN and p62 on damaged mitochondria. These findings suggest that microglial cells activate mitophagy to limit early inflammasome activity. However, although there is inflammasome activation following exposure to ssRNA40, there is limited LC3B lipidation and BECN1 expression indicating that autophagic flux fails to go to completion. We found that the turnover of autophagy receptors OPTN and p62 is reduced at 48 hr post-ssRNA40 treatment of microglia. In addition, caspase-1 activity is enhanced, and TBK1 phosphorylation and Parkin expression is reduced following prolonged exposure of microglial cells to ssRNA40, as observed previously with Pseudomonas aeruginosa exposed macrophages, where caspase-1 mediated cleavage of TRIF results in inhibition of autophagy (Jabir et al., 2014) .
Thus, unlike previously reported macrophage cell lines where inflammasome activation is regulated through autophagy, exposure of microglial cells to HIV ssRNA40 leads to a chronic inflammatory state with elevated levels of caspase-1 and IL-1β secretion (Shi et al., 2012) .
Pyroptosis, a highly inflammatory cell death, is characterized by loss of membrane integrity and secretion of large amounts of inflammatory cytokines (Bergsbaken, Fink, & Cookson, 2009 ). Some earlier studies have shown that autophagy can negatively regulate pyroptosis (Shi et al., 2012; Suzuki et al., 2007; Yu et al., 2014) . In agreement with these previous reports, our current findings also suggest that persistent stimulation of microglial cells with HIV ssRNA40 triggers pyroptosis due to a blockade of autophagy mediated regulation of inflammasome activity.
In summary, we showed here that HIV GU-rich ssRNA activates microglial cells via the NLRP3 inflammasome pathway, and can significantly contribute to neurotoxicity and neurodegeneration via secretion of inflammatory and neurotoxic cytokines. Blockade of autophagy/ mitophagy mediated negative regulation of inflammasome activity leads to excessive release of inflammatory cytokines, caspase-1 activation, pyroptotic cell death of microglial cells and neurotoxicity that can contribute to the cognitive deficits and chronic inflammation commonly seen in HIV-infected individuals on suppressive antiretroviral treatment. 
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